ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ICU SeaStar Medical Holding Corporation

0.4551
-0.0382 (-7.74%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
SeaStar Medical Holding Corporation ICU NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0382 -7.74% 0.4551 13:00:10
始値 安値 高値 終値 前日終値
0.49 0.4421 0.5093 0.4486 0.4933
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3021:30GLOBESeaStar Medical Announces $3.6 Million NIH Grant Award to..
2024/4/1805:00GLOBESeaStar Medical Reports 2023 Financial Results and Provides..
2024/4/1121:30GLOBESeaStar Medical to Present at the Noble Capital Markets’..
2024/3/2721:30GLOBESeaStar Medical to Restate Financials, Sets Business Update..
2024/3/1221:30GLOBESeaStar Medical Provides Updates on Enrollment of Adult..
2024/3/1205:05GLOBESeaStar Medical-Sponsored Symposium Featuring Experts..
2024/2/2722:30GLOBEManuscript Discussing the Benefit of SeaStar Medical’s..
2024/2/2221:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
2024/2/2221:53GLOBEFDA Grants Humanitarian Device Exemption Approval to SeaStar..
2024/2/0122:30GLOBESeaStar Medical Granted Canadian Patent with Broad Claims..
2024/1/2622:05GLOBESeaStar Medical Announces Pricing of $9.0 Million Registered..
2024/1/1206:05GLOBESeaStar Medical Appoints David A. Green as Chief Financial..
2024/1/0922:30GLOBESeaStar Medical Issued U.S. Patent with Broad Claims..
2023/12/2822:30GLOBESeaStar Medical Updates Subject Enrollment in its Pivotal..
2023/12/1322:30GLOBESeaStar Medical Forms Scientific Advisory Board of..
2023/11/1506:04GLOBESeaStar Medical Reports Third Quarter 2023 Financial Results..
2023/10/3121:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
2023/10/3021:00GLOBEFDA Issues Approvable Letter for SeaStar Medical’s Selective..
2023/10/1821:30GLOBEFDA Grants SeaStar Medical’s Selective Cytopheretic Device..
2023/10/0521:30GLOBESeaStar Medical to Present at the Dawson James Small Cap..
2023/10/0405:05GLOBESeaStar Medical Provides Regulatory Update Regarding..
2023/9/2921:30GLOBEFDA Grants Breakthrough Device Designation to SeaStar..
2023/9/2122:35GLOBEDawson James Securities Announces October Date for 8th..
2023/8/3105:35EDGAR2Form 8-K - Current report
2023/8/2921:00GLOBECase Series of Three Critically Ill Children with Acute..
2023/8/2506:15EDGAR2Form 8-K - Current report
2023/8/2221:00GLOBESeaStar Medical to Hold Business Update Conference Call..
2023/8/1806:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1806:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1806:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1605:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1605:43EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1605:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1605:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1519:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1519:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1519:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1519:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1519:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1506:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1505:36EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/1505:35GLOBESeaStar Medical Reports Second Quarter 2023 Financial..
2023/8/1505:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1105:00EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
2023/8/0305:19EDGAR2Form 8-K - Current report
2023/8/0113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/7/2106:11EDGAR2Form S-1 - General form for registration of securities under..
2023/7/0606:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

最近閲覧した銘柄

Delayed Upgrade Clock